Netherlands· NL-166bfdf6d715

Neupro 4 mg/24 h pleister voor transdermaal gebruik

A rotigotine product containing rotigotine, registered in Netherlands by UCB Pharma S.A.. The same ATC class is registered in 18 of our 19 countries.

ATC N04BC09

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about rotigotineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Rotigotine is registered in 18 of 19 countries.

Countries holding a registration under ATC N04BC09 (rotigotine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search rotigotine products by name

Rotigotine · ATC N04BC09

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rotigotine costs, country by country.

Normalised to the WHO defined daily dose (6 mg), the median price runs from $0.77 in Czechia to $4.34 in Switzerland — a ×5.6 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Rotigotine · price per daily dose (6 mg)

USD · FX 28 Sept 2026

CH Switzerland$4.34
CZ Czechia$0.77

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ROTIGOTINE
Manufacturer: UCB Pharma S.A.
Country: Netherlands (NL)
ATC code: N04BC09
ATC class: Rotigotine
Defined daily dose: 6 mg, TD
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/05/331

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

58 interactions on record for rotigotine.

Graded by severity as the source publishes them — 58 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check rotigotine against other medicines How interaction checks work

Rotigotine · interactions on record

58 records

58 moderate

Most severe, free to view

MetoclopramideA03FA01moderate
ThiethylperazinA04AB03moderate
DiphenhydraminA04AB05moderate
DronabinolA04AD10moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rotigotine in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rotigotine products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

Austria · Kinparlev, Rotigotin Gebro
Germany · Rotigotin Luye, Rotigotin Neuraxpharm
Denmark · Kinparlev, Rotigotine Medical Valley
Spain · Dariante
Finland · Kinparlev, Rotigotine Medical Valley
France · Rotigotine Arrow
Greece · Kinparlev
Iceland · Neupro, Rotigotine Medical Valley
Italy · Rotigotina Doc
Liechtenstein · Neupro
Luxembourg · Rotigotin Luye
Norway · Kinparlev, Neupro
Portugal · Kinparlev, Rotigotina Generis
Romania · Kinparlev
Sweden · Kinparlev, Rotigotine Medical Valley

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/49b4713c-f36c-49bf-b22c-e703bc4b83be
GET /v1/drugs/49b4713c-f36c-49bf-b22c-e703bc4b83be?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pleister voor transdermaal gebruik",
  "route": "Transdermaal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/neupro-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Rotigotine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp72670",
  "excipients": [
    "ALUMINIUMHYDROXIDE 0-WATER",
    "ASCORBYLPALMITAAT (E 304)",
    "BEIGE INKT",
    "COPOLYMEER VAN ETHYLACRYLAAT-2-ETHYLHEXYLACRYLAAT",
    "COPOLYMEER VAN POLY(DIMETHYLSILOXAAN-HYDROXIDE)(19,9)-TRIMETHYLSILYLSILICAATHARS(43,5)-HEXAMETHYLDISILAZAAN(9,9)",
    "COPOLYMEER VAN POLY(DIMETHYLSILOXAAN-HYDROXIDE)(22,6)-TRIMETHYLSILYLSILICAATHARS(38,6)-HEXAMETHYLDISILAZAAN(11,3)",
    "EPOXYHARS",
    "EPOXYHARS",
    "NATRIUMMETABISULFIET (E 223)",
    "PIGMENT GEEL 95",
    "PIGMENT GEEL 95",
    "PIGMENT ROOD 144",
    "PIGMENT ROOD 166",
    "PIGMENT ZWART 7",
    "POLYAMINOAMIDE HARS",
    "POLYAMINOAMIDE HARS",
    "POLYETHYLEENTEREPHTHALAAT, GEFLUORIDEERD",
    "POLYETHYLEENTEREPHTHALAAT, GESILICONEERD EN BEKLEED MET ALUMINIUM",
    "POLYPROPYLEEN",
    "POLYPROPYLEEN",
    "POVIDON K 90 (E 1201)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)",
    "TOCOFEROL, DL-ALFA (E 307)"
  ],
  "substances": [
    "ROTIGOTINE"
  ],
  "leaflet_url": null,
  "authorised_at": "2006/02/15",
  "procedure_number": "EMEA/H/C/000626",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/05/331",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about rotigotine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console